-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RVQAn2jYHYum1G6CI636309KCFCtq3YLvwImSC9DgXWtCM8PJQFMKiIauYIC+6Bi Ds5Fw5k68+HoDxCcoEeOuA== 0001019687-04-001479.txt : 20040702 0001019687-04-001479.hdr.sgml : 20040702 20040702150528 ACCESSION NUMBER: 0001019687-04-001479 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040702 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRIMEDEX HEALTH SYSTEMS INC CENTRAL INDEX KEY: 0000790526 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133326724 STATE OF INCORPORATION: NY FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19019 FILM NUMBER: 04899544 BUSINESS ADDRESS: STREET 1: 1516 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 3104787808 MAIL ADDRESS: STREET 1: 1516 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: CCC FRANCHISING CORP DATE OF NAME CHANGE: 19920703 8-K 1 primedex_8k-070204.txt ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of the earliest event reported): July 2, 2004 _________________ PRIMEDEX HEALTH SYSTEMS, INC. (Exact name of registrant as specified in its charter) New York 0-19019 13-3326724 (State or other jurisdiction of (Commission File Number) (IRS Employer incorporation or organization) Identification No.) 1510 Cotner Avenue Los Angeles, California 90025 (Address of principal executive offices) (Zip Code) (310) 478-7808 (Registrant's telephone number, including area code) ================================================================================ ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits EXHIBIT NUMBER DESCRIPTION -------------- ----------- 99.1 Press release dated July 2, 2004. ITEM 9. REGULATION FD DISCLOSURE. On July 2, 2004, Primedex Health Systems, Inc. issued a press release announcing an agreement in principle to restructure its outstanding approximately $160 Million credit arrangements utilizing its current lenders. The press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference. The information in this Current Report on Form 8-K, including the exhibits thereto, will not be treated as filed for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. This information will not be incorporated by reference into a filing under the Securities Act of 1933, or into another filing under the Securities Exchange Act of 1934, unless that filing expressly refers to specific information in this report. ---------------------------------------------------------------- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 2, 2004 PRIMEDEX HEALTH SYSTEMS, INC. By: /s/ Howard G. Berger, M.D. ----------------------------- Howard G. Berger, M.D. President - -------------------------------------------------------------------------------- -1- EXHIBIT INDEX EXHIBIT NUMBER DESCRIPTION 99.1 Press release dated July 2, 2004. -2- EX-99.1 2 primedex_8kex99-1.txt PRESS RELEASE DATED JULY 2, 2004 EXHIBIT 99.1 PRIMEDEX HEALTH SYSTEMS, INC. ANNOUNCES PRELIMINARY AGREEMENT TO RESTRUCTURE DEBT July 2, 2004, Los Angeles, California. Primedex Health Systems, Inc. (OTCBB:PMDX) announced today it has reached an agreement in principal to restructure its outstanding approximate $160 Million credit arrangements utilizing its current lenders. The proposed arrangements involve a revision and extension of the terms of the outstanding Primedex obligations to those entities. The contemplated arrangement with the Primedex existing lenders is intended to replace the previously sought third-party financing arrangements. While the revised financing arrangements with the Primedex existing lenders will not result in a reduction in the Primedex outstanding debt as previously contemplated, it will provide a payment schedule designed to facilitate the current operations of Primedex. The replacement lending facility is expected to be in place by July 31, 2004. Inasmuch as an agreement in principle only has been reached, no assurance can be given that the agreement as now contemplated will be reached or any agreement at all. Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including but not limited to general business conditions, market conditions for corporate debt in general and credit facility lending in particular and other risks described from time to time in Primedex's SEC reports, including its report on Form 10-K for the year ended October 31, 2003 and on Form 10-Q for the quarter ended April 30, 2004. Company Contact: Jeffrey Linden General Counsel (310) 445-2842 -3- -----END PRIVACY-ENHANCED MESSAGE-----